Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
Credit: Fred Hutch News Service SEATTLE (March 24, 2017) - The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio...










